The U.S. Patent and Trademark Office has awarded Solace Lifesciences a patent for NuCalm, a technology designed to relieve stress in dental patients.
NuCalm involves a four-step system to bring patients into a state of deep relaxation without using drugs. Neuroacoustic software initiates a change in brain waves, a behind-the-ear patch allows microcurrent stimulations, and a mask blocks light. Solace Lifesciences successfully tested the technology on more than 400,000 dental patients.
"This is the world's only patent granted for 'Systems and Methods for Balancing and Maintaining the Health of the Human Autonomic Nervous System,' " James Poole, Solace Lifesciences' president and CEO, said in a press release. "It has been a 13-year journey to this point."
%20nov12024.q9h8imREpF.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=100&w=100&auto=format%2Ccompress&q=70)
%20nov12024.q9h8imREpF.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=167&w=250&auto=format%2Ccompress&q=70)
